SAN JOSE, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading global platform for digital health solutions, has announced that Stephen J. Ubl, President and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA), has been appointed as an independent director to its Board of Directors. Mr. Ubl brings over 25 years of leadership experience in the healthcare sector to BrightInsight. This strategic addition comes as the company continues to prove sustained impact, at scale, across various disease areas and therapeutic fields.

Read more here.